Teladoc Health, Inc. (TDOC) declined in the after-hours market after announcing its fourth quarter and fiscal 2021 results. TDOC values at $62.16, losing more than 4.8% compared to yesterday’s closing price. The stock closed at $65.30 at the end of the last trading session. The stock volume traded in the last trading session was around 4.21 million shares. The current market cap of the company is around $10.45 billion.
TDOC: Key Financials
- Teladoc Health, Inc. (TDOC) revenue in Q4 2021 was $554.2 million. It is a gain of more than 45% compared to the revenue of Q4 in 2020. The Q4 2020 revenue was $383.3 million.
- Fiscal year revenue was $2.03 billion, and it is an increase of more than 86% compared to the revenue in fiscal 2020. The fiscal 2020 revenue was $1.09 billion.
- The company’s net loss in Q4 2021 was around $11 million. The net loss was $394 million in Q4 2020.
- TDOC net loss in fiscal 2021 was around $428.8 million, compared to the net loss of $485.1 million in fiscal 2020.
- The Q4 2021 loss per share was $0.07.
- For fiscal 2021, the loss per share was $2.73.
TDOC CEO’s Remarks
Teladoc Health CEO Jason Gorevic said that Teladoc Health made excellent progress in 2021 in providing complete whole-person care. We met our goals, earned our clients’ trust, and connected millions of people to exceptional treatment. We will always be the first choice for customers seeking healthcare.
Teladoc Health’s extensive virtual care services link chronic, primary, acute, and specialist care patients. We saw substantial growth and penetration in various crucial areas of our firm using BetterHelp direct-to-consumer and MyStrength Complete B2B2C strategies for proper treatment at the perfect time.
TDOC 2022 Outlook
The company has provided its expected financial numbers in light of the uncertain situation of a pandemic. TDOC expects revenue between $565 million to $571 million in the first quarter of 2022. For fiscal 2022, the company expects revenue between $2.55 million to $2.65 billion. They expect a loss per share of $0.60 to $0.50 in Q1, and for fiscal 2022 it anticipates a loss per share of $$1.60 to $1.40.
Conclusion
The company’s revenue guidance shows a gain of around 25 to 30%. The company is focusing on increasing its market share and reaching more target audiences. That is why its revenue is increasing but is not profitable yet. They are focusing on the company’s growth, and profitability is the later part of such strategies.
